CLINICAL APPLICATION OF GLP-1 IN LIPID METABOLISM AND ADIPOSE-RELATED DISORDERS Effects of glp-/glucose-dependent insulinotropic peptide dual agonists on lipid metabolism GLP-/glucose-dependent insulinotropic peptide (GIP) dual agonists are a new type of oral hypoglycemic drug, which can activate both GLP-1 and GIP incretin at the same time, thereby exerting a more comprehensive blood glucose control effect [125]
Every time I called, an automated prompt told me that all their customer service agents are assisting other patients and to leave a voicemail
For retatrutide, TRIUMPH-4 enrolled 445 adults living with obesity and knee osteoarthritis, and followed them for 68 weeks
This combination should only be initiated and monitored by a clinician, in line with BNF and NICE guidance
If the blues, anxiety, or anger become overwhelming, seeking help is essential
What time of day affects is your experience of the drug when peak side effects hit, how it interacts with your sleep, and whether it disrupts your training schedule